Programmed RNA breakage is an emerging theme underlying cellular responses to stress, virus infection and defense against foreign species. In many cases, site-specific cleavage of the target RNA generates 2 0 ,3 0 cyclic phosphate and 5 0 -OH ends. For the damage to be repaired, both broken ends must be healed before they can be sealed by a ligase. Healing entails hydrolysis of the 2 0 ,3 0 cyclic phosphate to form a 3 0 -OH and phosphorylation of the 5 0 -OH to form a 5 0 -PO 4 . Here, we demonstrate that a polynucleotide kinase-phosphatase enzyme from Clostridium thermocellum (CthPnkp) can catalyze both of the end-healing steps of tRNA splicing in vitro. The route of tRNA repair by CthPnkp can be reprogrammed by a mutation in the 3 0 end-healing domain (H189D) that yields a 2 0 -PO 4 product instead of a 2 0 -OH. Whereas tRNA ends healed by wild-type CthPnkp are readily sealed by T4 RNA ligase 1, the H189D enzyme generates ends that are spliced by yeast tRNA ligase. Our findings suggest that RNA repair enzymes can evolve their specificities to suit a particular pathway.
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INTRODUCTION
'RNA repair' is a versatile mechanism to rectify programmed breaks in tRNAs and mRNAs incurred during tRNA processing and under conditions of cellular stress. Examples include virus-mediated tRNA repair to thwart a host antiviral response to bacteriophage infection (1), splicing of intron-containing tRNAs (2) and unconventional mRNA splicing during the unfolded protein response (3, 4) . In each of these cases, the inciting event is a site-specific endonuclease cleavage of the target RNA to generate a 2 0 ,3 0 cyclic phosphate end and a 5 0 -OH end. Both broken ends must be healed before they can be sealed by an RNA ligase. Healing entails hydrolysis of the Figure 1A ). The ligase domain, Trl1(1-388), then joins the healed ends to form a tRNA with a 2 0 -PO 4 , 3 0 -5 0 phosphodiester at the splice junction. [The junction 2 0 -PO 4 is ultimately removed by a phosphotransferase, Tpt1, that is specific to the yeast tRNA repair pathway (11) ].
Recent studies highlight a plethora of target-specific endoribonuclease toxins in bacteria (12) (13) (14) (15) (16) (17) (18) and fungi (19) and their role in defending the organism against non-self species and viruses. This raises the question of whether RNA repair systems exist in bacterial cells as a means of evading programmed RNA breakage. Our identification of candidate RNA healing and sealing enzymes in several bacterial proteomes (20, 21) suggests an RNA repair capacity, but the scant knowledge of the genetics and ecology of those bacteria provides no clues to what types of RNA damage might be subject to repair. Here, we demonstrate that an enzyme from Clostridium thermocellum (CthPnkp) can catalyze both of the end-healing steps of tRNA splicing in vitro. The biochemical pathway of tRNA repair by the CthPnkp can be reprogrammed by a mutation in the 3 0 end-healing domain that yields a 2 0 -PO 4 product instead of a 2 0 -OH.
MATERIALS AND METHODS

Recombinant T4 and yeast tRNA repair enzymes
His 10 -tagged versions of T4 Rnl1, T4 Pnkp and yeast Trl1(1-388) were produced in E. coli and purified from soluble lysates by Ni-agarose chromatography as described previously (8, 22, 23) . Yeast Trl1(389-827) was produced in E. coli as a His-Smt3 fusion and recovered from a soluble extract by Ni-agarose chromatography. The His-Smt3 tag was removed with the Smt3-specific protease Ulp1 and the tag-free Trl1(398-927) protein was recovered in the flow-through fraction during a second round of Ni-agarose chromatography. SDS-PAGE analysis of the enzyme preparations is shown in Figure 2 .
Recombinant CthPnkp
Wild-type CthPnkp and mutated or truncated versions of CthPnkp were produced in E. coli as His 10 -tagged fusions and purified from soluble bacterial extracts by Ni-agarose chromatography (24, 25) . The 200-mM imidazole eluates were dialyzed against 150 mM NaCl in buffer A (50 mM Tris-HCl, pH 8.0, 10% glycerol, 1 mM EDTA, 1 mM b-mercaptoethanol) and then applied to 1-ml columns of DEAE-Sephacel that had been equilibrated in buffer A. The columns were washed with 5 ml of buffer A and then eluted stepwise with 200 and 500 mM NaCl in buffer A. The CthPnkp proteins were recovered in the DEAE flowthrough, apparently free of contaminating nucleic acids (which were detected in the 0.5 M NaCl eluate). SDS-PAGE analysis of the CthPnkp preparations is shown in Figure 2 .
Synthesis of pre-tRNA in vitro
The intron-containing pre-tRNA is a chimera consisting of the mature tRNA sequence of plant pre-tRNA Tyr plus the intron and anticodon of Methanocaldococcus pretRNA Trp (26) . This pre-tRNA was generated by in vitro transcription of BstN1-cut plasmid pNtY9-T7-M1 by T7 RNA polymerase in the presence of [a 32 P]ATP. A reaction mixture (100 ml) containing 80 mM HEPES-KOH (pH 7.5), 24 mM MgCl 2 , 40 mM DTT, 2 mM spermidine, 2.5 mM CTP, UTP and GTP, 0.5 mM [a-32 P]ATP, 5 mg template DNA, 120 units RNAsin (Promega), 0.5 units yeast inorganic pyrophosphatase (Sigma) and 300 units T7 RNA polymerase (New England Biolabs) was incubated for 3 h at 378C. The labeled pre-tRNA was purified by electrophoresis through an 8% polyacrylamide-urea gel. The pre-tRNA was eluted from an excised gel slice in Cleavage of the pre-tRNA with archaeal-splicing endonuclease pre-tRNA cleavage reaction mixtures (100 ml) containing 50 mM Tris-HCl (pH 7.5), 100 mM KCl, 10 mM MgCl 2 , 1 mM DTT, 40 mM spermine, 40 pmol [ 32 P[AMP-labeled pre-tRNA and 1.5 mg Methanocaldococcus jannaschii tRNA-splicing endonuclease (produced in E. coli as a His 10 fusion and purified by Ni-agarose chromatography) were incubated for 20 min at 658C. The RNA products were phenol-extracted, precipitated with ethanol (28-32 pmol of cleaved tRNA recovered), resuspended in 100 ml of 10 mM Tris-HCl (pH 8.0), 1 mM EDTA and stored at À208C.
RESULTS AND DISCUSSION
Distinct tRNA repair pathways in vitro
The finding that the essential healing and sealing components of the yeast tRNA-splicing system can be replaced in vivo by their bacteriophage analogs (27) attested to the portability of RNA repair systems from widely distant taxa. However, certain restrictions apply. To better delineate the specificity of end-healing and end-sealing during tRNA repair/splicing, we exploited an in vitro tRNA-splicing system designed by Englert and Beier (26) . The broken tRNA substrate was generated by treating a 32 P-labeled intron-containing pre-tRNA with a tRNA-splicing endonuclease, which led to quantitative release of a linear 21-nt intron and the formation of two 'half-tRNA' molecules: a 37-nt 5 0 fragment and a 39-nt 3 0 -fragment ( Figure 1B) . Reaction of the broken RNA with a combination of yeast Trl1(1-388) and Trl1(389-827) resulted in a mature spliced tRNA and the circularization of the intron. Splicing of the tRNA halves and intron circularization were also seen with T4 Rnl1 plus T4 Pnkp. However, the ligase domain of yeast Trl1 was unable to splice the tRNA or circularize the intron when paired with T4 Pnkp ( Figure 1B ). This in vitro observation echoes precisely the inability of Trl1(1-388) to function together with T4 Pnkp in vivo. This incompatibility reflects a requirement for a 3 0 -OH, 2 0 -PO 4 terminus in order for the ligase component of Trl1 to seal the broken RNA ends in vitro.
Clostridium Pnkp performs the end-healing steps of tRNA repair
CthPnkp catalyzes the phosphorylation of 5 0 -OH termini of DNA or RNA polynucleotides and the dephosphorylation of 2 0 ,3 0 cyclic phosphate, 2 0 -phosphate and 3 0 -phosphate ribonucleotides (21, 24, 25) . These characteristics are consistent with a role in end healing during RNA or DNA repair. CthPnkp is an 870-aa polypeptide composed of three catalytic domains: an N-terminal module that resembles the kinase domain of T4 Pnkp, a central phosphoesterase module and a C-terminal module that resembles the adenylyltransferase domain of polynucleotide ligases. The distinctive feature of CthPnkp vis a vis known repair enzymes is that its 3 0 end modification component belongs to the binuclear metallophosphoesterase superfamily (24, 25) . The salient question is whether CthPnkp can perform a bona fide RNA repair reaction and, if so, to which of the two known repair pathways it adheres. We found that CthPnkp functioned in tRNA splicing in vitro as the sole source of end-healing activity when added in tandem with T4 Rnl1, resulting in the formation of a spliced tRNA product and an intron circle (Figure 3 ). However, splicing activity was attenuated severely when yeast Trl1(1-388) replaced phage Rnl1 as the source of the RNA sealing activity (Figure 3) . We surmise that the predominant outcome of CthPnkp healing of a tRNA 2 0 ,3 0 cyclic phosphate end is not the 3 0 -OH, 2 0 -PO 4 required by yeast tRNA ligase.
Mechanism of 3 0 end healing by CthPnkp
To better address how CthPnkp acts at a 2 0 ,3 0 cyclic phosphate end, we compared the release of inorganic phosphate (P i ) from 2 0 ,3 0 cAMP by CthPnkp alone versus a duplicate sample in which the products were treated with calf intestinal phosphatase (CIP) prior to assay of P i release ( Figure 4A) Studies of the catalytic mechanism of the CthPnkp phosphoesterase have shown it to be plastic, insofar as certain mutations in the active site alter the reaction outcome (25) . In particular, an H189D change abolished the phosphomonoesterase activity with p-nitrophenylphosphate as a substrate, without affecting the phosphodiesterase activity with bis-p-nitrophenylphosphate (25) . Here, we find that CthPnkp-H189D failed to release inorganic phosphate from 2 0 ,3 0 cAMP, while converting 88% of the input 2 0 ,3 0 cAMP to a monoester that was hydrolyzed by CIP ( Figure 4A ). The reaction in substrate excess proceeded to near completion with apparent pseudo-firstorder kinetics ( Figure 4B ) at an initial rate of 20 s À1 . The transformation of CthPnkp into a CPD-only end-healing enzyme by the H189D mutation allowed us to probe the outcome of the CPD reaction, by performing TLC analysis of the reaction mixture as a function of reaction time in the presence of CthPnkp only (no CIP). This revealed a single-step conversion of 2 0 ,3 0 cAMP to a faster moving product that comigrated with 2 0 AMP ( Figure 4C ). We infer that a 2 0 phosphomonoester is the relevant intermediate in tRNA end healing by wild-type CthPnkp.
The H189D change alters the pathway of tRNA repair
Testing the activity of CthPnkp-H189D in tRNA splicing revealed that its RNA repair specificity had been transformed so that its healing activity was now channeled through the yeast-type repair pathway. H189D exhibited a gain of function in working with the yeast ligase to perform both tRNA splicing and intron circularization ( Figure 5 ). CthPnkp-H189D had no repair activity in the absence of Trl1(1-388) (not shown). Moreover, a truncated version of H189D (aa 1-472) containing just the kinase and phosphoesterase modules retained full activity in tRNA splicing in combination with Trl1(1-388) ( Figure 5) . Thus, the C-terminal adenylyltransferase domain of CthPnkp was noncontributory to the observed tRNA repair activity. We introduced into the H189D-healing domain a second mutation in the ATP-binding motif of the polynucleotide kinase module. The K21A change abolished 5 0 kinase activity, without impacting the cyclic phosphoesterase function ( Figure 6 ). The K21A-H189D double mutant was inert in tRNA repair ( Figure 5 ), proving that the bacterial enzyme is the source of the 5 0 end-healing function for tRNA splicing in vitro.
CONCLUSIONS
The present study illuminates several aspects of RNA repair: (i) the demonstration of a repair-competent RNA end-healing enzyme encoded by a bacterium (to our knowledge, the first case so documented); (ii) repair pathway choice based on the compatibility of the 3 0 endhealing and sealing reaction specificities; and (iii) the ability to reprogram the choice of repair pathway by a single missense mutation in the 3 0 end-healing component. These properties suggest that RNA repair enzymes and pathways can quickly evolve (or co-evolve) their specificities to suit a particular biological context, e.g. the CPD reaction chemistry and stringent specificity of yeast Trl1 for a 3 0 -OH, 2 0 -PO 4 terminus ensures avoidance of sealing RNA ends not generated by programmed cleavage events (27) .
Although CthPnkp is clearly tRNA repair-competent in vitro, our initial attempts to replace Trl1(389-827) with CthPnkp-H189D in vivo in yeast were not successful. We suspect that the non-portability of this RNA repair enzyme reflects idiosyncratic aspects of foreign protein expression or localization in budding yeast, rather than any mechanistic deficit, insofar as we were also unable to complement a Saccharomyces cerevisiae trl1Á strain with the Trl1 ortholog from fission yeast Schizosaccharomyces pombe.
Based on the detection of CthPnkp-like proteins with similar size and domain organization in many other bacterial genera (Bacillus, Helicobacter, Fusobacterium, Herpetosiphon and Maricaulis), we propose that bacterial RNA repair is hiding in plain sight. 
